O, Spiro AC, Karram K, Choudhary K, Okabe S, McKay RD, et al .
Peterson and Robert Marr for the study "Reprogramming Cell Fate for Repair," a collaboration with investigators Oliver Brustle
and Martin Schwarz of the University of Bonn (Germany).
2010); Enrico Bonadio, Biotech Patents and Morality After Brustle
4) Only one previous case of PNET after NHL has been reported, as described by Brustle
, et al.
(Case C-34/10) the CJEU held that a 'human embryo' included "non-fertilised human ovum whose division and further development have been stimulated by parthenogenesis" as they were "capable of commencing the process of development of a human being just as an embryo created by fertilisation of an ovum can do so.
Les initiateurs demandent a l'UE d'interdire et de mettre fin au financement des activites qui impliquent la destruction d'embryons humains, en particulier dans les domaines de la recherche, de l'aide au developpement et de la sante publique, parce que, dans leur opinion, <<la dignite et l'integrite de l'embryon humain doivent etre respectees >>, en mentionnent l'arret Brustle
The European Union's highest court was asked to clarify whether its interpretation of the EU Directive on Legal Protection of Biotechnological Inventions ("Biotech Directive") in the 2011 Brustle
Mark Nickas, Discordant Harmonization: Did the European Court of Justice Interpret the Biotechnology directive's Exclusions to Patentability Too Broadly in Brustle
Blanpain blasted the EU Court of Justice ruling in the case of Greenpeace versus Brustle
18, the European Court of Justice (ECJ) delivered a blow to stem cell researchers and the institutions that fund them with its ruling in Oliver Brustle
De manera similar, recientemente, el abogado general del Tribunal de Justicia Europeo considera que en una invencion no se puede conceder una patente si un embrion humano es destruido (C-34/10) Oliver Brustle
v Greenpeace eV  Dictamen del Abogado General Bot.
The dispute pits a German professor, Oliver Brustle
, who holds a patent on neural cells produced from human embryonic stem cells, against Greenpeace, which challenged the patent and obtained a ruling invalidating it, in 2006, on the basis of the German law that rules out the commercial use of human embryos.